Co-Promotion of Anti-Allergic Drug, "Allelock Tablets"
August 22, 2003
Kyowa Hakko Kogyo Co., Ltd. (Chiyoda-ku Tokyo, President: Yuzuru Matsuda) and Kyorin Pharmaceutical Co., Ltd. (Chiyoda-ku Tokyo, President: Ikuo Ogihara) have agreed to co-promote (co-promotion: 1 brand, 1 channel) in Japan the sale of an anti-allergic drug, "Allelock® Tablets 2.5 mg"/"Allelock® Tablets 5 mg" (nonproprietary name: olopatadine hydrochloride) currently being manufactured and sold by Kyowa Hakko. The co-promotion begins from October 1, 2003 and focuses towards general practitioners with less than 100 beds (hereinafter referred to as "GP").
"Allelock® Tablets" were created and developed by Kyowa Hakko and launched into the Japanese market on March 6, 2001. Since then, the drug has been highly rated as a therapeutic drug for allergic diseases because of the following characteristics
Adobe Reader software is required to view and print PDF files. The latest version of Adobe Reader can be downloaded by accessing the Adobe Systems Incorporated website.